UK health experts have identified what they believe is the 10 most important medicines and vaccines launched on the NHS in the past 70 years. The list includes two vaccines which prevent polio and measles, mumps and rubella in addition to medicines that have transformed HIV/AIDS from a death sentence to a manageable condition, immunosuppressants
Senior Medical AdvisorOnly MedicsBuckinghamshire, UK
- Full Time
Resourcer / Associate ConsultantOnly MedicsBerkshire, UK
- Full Time
Medical Advisor – DiabetesOnly MedicsHampshire, UK
- Full Time
Medical Advisor – BiologicsOnly MedicsLondon East, UK
- Full Time
Drug Safety SpecialistOnly MedicsHertfordshire, UK
Recruiting Physicians for Pharma
Only Medics is a specialist international medical recruitment company that focuses exclusively on the recruitment of pharmaceutical physicians for pharmaceutical companies, biotechnology companies, Clinical Research Organisations (CROs) and Regulatory Authorities.
We successfully recruit on both a contingent and retained basis on permanent positions as well as interim medical assignments. Our geographic reach is truly global and although our main focus is the European job market, we also recruit for pharmaceutical physician jobs in the US, Canada, Australia and Asia Pacific.
Created in 2005, Only Medics was the first of its kind: a niche specialist recruitment organisation catering solely to the need of physicians. Since then, Only Medics has distinguished itself as the market-leader in its field recruiting for more than 90 european organisations including many of the ‘top 10’ pharma. Today Only Medics is established as the medical recruitment company of choice and has attained an exclusive or preferred supplier for many organisations from global pharma through medium and small-sized companies to start-up ventures, CROs, Biotech companies and national regulatory bodies.
With first-hand experience of working in the pharmaceutical/CRO and recruitment sectors, we have a detailed understanding of jobs for pharmaceutical physicians.
Candidates enjoy the organisation’s sole focus on their market place and an unrivalled range of career options from across the continent and beyond. Furthermore we offer in-depth career analysis and active steps to better prepare for interview success.
Clients are presented with the most highly sought-after local or international medical experts for their challenging positions. We submit well-prepared candidates who meet the recruitment brief and provide superior guarantee of interview success and fast assignment-to-completion times.
The government has launched consultation on proposed changes to the statutory scheme for pharmaceutical pricing that would include biosimilars in the scope of its price controls. The statutory scheme covers those companies who don’t sign on to the voluntary Pharmaceutical Price Regulation Scheme (PPRS). To coincide with the new PPRS scheme, expected to come into
Almirall, S.A. has announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has issued a positive opinion for the regulatory approval of tildrakizumab, an investigational humanised, high-affinity IL-23p19 monoclonal antibody for adults with moderate-to-severe chronic plaque psoriasis. Tildrakizumab is an innovative biological drug due to its specific mechanism of action.